Related Experiment Video
Updated: Apr 4, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014
Mehmet Ceyhan1, Yasemin Ozsurekci1, Nezahat Gürler2
1a Department of Pediatric Infectious Diseases ; Hacettepe University Faculty of Medicine ; Ankara , Turkey.
Insights
Pneumococcal conjugate vaccines (PCV) in Turkey show changing serotype distributions, with decreased vaccine-type coverage and increased non-vaccine types. Ongoing surveillance informs vaccination policy decisions for invasive pneumococcal diseases (IPD).
Area of Science:
- Microbiology and Immunology
- Vaccinology
- Public Health
Background:
- Effective vaccination policies against invasive pneumococcal diseases (IPD) require precise serotype distribution data.
- Turkey's National Immunization Program transitioned from 7-valent (PCV-7) to 13-valent (PCV-13) pneumococcal conjugate vaccines.
- Understanding serotype shifts is crucial for optimizing IPD prevention strategies.
Purpose of the Study:
- To identify pneumococcal serotypes causing IPD in Turkish children.
- To analyze serotype changes before and after the introduction of PCV-7 and the switch to PCV-13.
- To assess the impact of vaccination on serotype distribution and antibiotic susceptibility.
Main Methods:
- Isolation and serotyping of Streptococcus pneumoniae strains from 335 IPD cases across 22 Turkish hospitals (2008-2014).
- Analysis of vaccine serotype coverage for PCV-7, PCV-10, and PCV-13 in children under five.
- Comparison of non-vaccine serotype ratios and penicillin non-susceptibility over time.
Main Results:
- The most common vaccine serotypes identified were 19F, 6B, 14, and 3.
- Potential serotype coverage decreased over time for PCV-7, PCV-10, and PCV-13.
- The proportion of non-vaccine serotypes increased significantly from 27.2% (2008-2010) to 37.6% (2011-2014), and penicillin non-susceptibility decreased (33.7% to 16.5%).
Conclusions:
- Observed reductions in vaccine serotype coverage may reflect increased vaccination rates.
- The rise in non-vaccine serotypes suggests serotype replacement following vaccination.
- Continuous IPD surveillance is vital for informing and adapting national pneumococcal vaccination policies in Turkey.
Abstract:
Successful vaccination policies for protection from invasive pneumococcal diseases (IPD) dependent on determination of the exact serotype distribution in each country. We aimed to identify serotypes of pneumococcal strains causing IPD in children in Turkey and emphasize the change in the serotypes before and after vaccination with 7-valent pneumococcal conjugate vaccine (PCV-7) was included and PCV-13 was newly changed in Turkish National Immunization Program. Streptococcus pneumoniae strains were isolated at 22 different hospitals of Turkey, which provide healthcare services to approximately 65% of the Turkish population. Of the 335 diagnosed cases with S. pneumoniae over the whole period of 2008-2014, the most common vaccine serotypes were 19F (15.8%), 6B (5.9%), 14 (5.9%), and 3 (5.9%). During the first 5 y of age, which is the target population for vaccination, the potential serotype coverage ranged from 57.5 % to 36.8%, from 65.0% to 44.7%, and from 77.4% to 60.5% for PCV-7, PCV-10, and PCV-13 in 2008-2014, respectively. The ratio of non-vaccine serotypes was 27.2% in 2008-2010 whereas was 37.6% in 2011-2014 (p=0.045). S. penumoniae serotypes was less non-susceptible to penicillin as compared to our previous results (33.7 vs 16.5 %, p=0.001). The reduction of those serotype coverage in years may be attributed to increasing vaccinated children in Turkey and the increasing non-vaccine serotype may be explained by serotype replacement. Our ongoing IPD surveillance is a significant source of information for the decision-making processes on pneumococcal vaccination.
Related Concept Videos
Atypical Pneumonia
Infectious Diseases and Their Occurrence
Bacterial Gastroenteritis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

